3 unstoppable ASX 200 shares to buy and hold forever

These shares have smashed the market and look well-placed to continue this trend.

| More on:
A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the best ways to build your wealth is by investing in ASX 200 shares that can grow strongly over long periods.

But not all shares are capable of doing this. So, let's take a look at three unstoppable shares that have incredible track records and positive long-term growth outlooks.

They are as follows:

REA Group Ltd (ASX: REA)

REA Group is an unstoppable ASX 200 share that has made investors rich. Over the past 15 years, the realestate.com.au operator's shares have delivered an average total return of 20.8% per annum.

Its property platforms are embedded in how Australians buy and sell homes. That network effect has been built over decades and is incredibly difficult to replicate.

What drives REA's compounding is not just property market activity, but its ability to increase revenue per customer. Premium listings, data tools, and value-added services allow the company to grow even when transaction volumes are not booming.

Given its domination of the local market and its growing Indian business, the future looks bright for this ASX share.

ResMed Inc. (ASX: RMD)

Another ASX 200 share that has delivered strong returns for investors is ResMed. It has achieved an average total return of 16.95% per annum since 2016.

This medical device company operates in sleep apnoea and respiratory care, which are areas driven by long-term health trends rather than discretionary spending. Diagnosis rates continue to rise, and once patients are on therapy, they tend to stay there.

What makes ResMed particularly effective at compounding is how it blends hardware with software and data. Devices, masks, cloud platforms, and analytics all work together to create recurring revenue and long-term customer relationships.

Management estimates that the total addressable market for sleep apnoea is over 1 billion people. This gives ResMed a significant growth runway for the next decade and beyond.

TechnologyOne Ltd (ASX: TNE)

Finally, TechnologyOne is a classic example of quiet compounding. Over the past decade, this ASX 200 share has delivered an average total return of 20.2% per annum.

The company provides mission-critical software to governments, universities, and large organisations. These customers do not switch systems lightly, which gives TechnologyOne a sticky client base and highly predictable revenue.

In addition, its shift to a software-as-a-service model has been highly successful and fundamentally changed the business. Revenue visibility has improved, cash generation has strengthened, and recurring income has become a much larger part of the mix.

And with management confident that it can double in size every five years, this ASX share could be destined to outperform long into the future.

Motley Fool contributor James Mickleboro has positions in REA Group, ResMed, and Technology One. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed and Technology One. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A businessman compares the growth trajectory of property versus shares.
Growth Shares

Why these ASX growth stocks could be much bigger in 5 years

Let's see which growth stocks analysts believe are buys at current prices.

Read more »

A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.
Growth Shares

The best Australian shares to buy in 2026

Let's see why these could be among the best Australian shares to buy now.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Growth Shares

Forget PLS shares! This ASX growth stock is tipped to rise 60% by 2027

Could this beaten down stock follow PLS' lead and rebound strongly. Bell Potter thinks it could.

Read more »

2 smiling women looking at a phone.
Growth Shares

My 3 higher-risk, high-reward ASX stock recommendations for February 2026

For investors willing to accept uncertainty, selective risk can sometimes be rewarded.

Read more »

A couple and their baby sit together at their computer carrying out digital transactions and smiling happily.
Growth Shares

The bulls are coming: 2 of the best ASX growth shares to buy now to get ahead

When the bulls return, I think these shares could be in demand with investors.

Read more »

Man flies flat above city skyline with rocket strapped to back
Growth Shares

2 ASX growth stocks set to skyrocket in the next 12 months

Analysts are predicting returns of 80% to 130% from these stocks.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Growth Shares

3 underappreciated ASX growth shares I would buy with $1,000

Not all growth opportunities are obvious at first glance. These three ASX shares have earnings potential that may be underappreciated.

Read more »

US navy ship at sea.
Growth Shares

Another record in sight? Why this ASX defence stock is back in rally mode

EOS shares surge toward fresh highs as defence spending accelerates and a key South Korean contract decision looms.

Read more »